Earnings Call · Q3 FY2021·2021-11-03

Q3 21EPS +3.82%·Rev n/aQ2 21EPS -8.59%·Rev n/aQ1 21EPS -3.97%·Rev n/aQ4 20EPS -6.02%·Rev n/a⚠ consensus missing

AGIOS PHARMACEUTICALS, INC. AGIO

Holly Manning — Investor Relations

Dr. Jackie Fouse — Chief Executive Officer

Dr. Sarah Gowen — Chief Medical Officer

Darrin Miles — Chief Commercial Officer

Jonathan Biller — Chief Financial Officer

−0.3%1d on move date−0.9% vs SPY3d−8.2%5d−12.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AGIO calls or request research access.

More AGIO calls Browse calls Request research access